1. Home
  2. IMRX vs BRID Comparison

IMRX vs BRID Comparison

Compare IMRX & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • BRID
  • Stock Information
  • Founded
  • IMRX 2008
  • BRID 1932
  • Country
  • IMRX United States
  • BRID United States
  • Employees
  • IMRX N/A
  • BRID N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • BRID Specialty Foods
  • Sector
  • IMRX Health Care
  • BRID Consumer Staples
  • Exchange
  • IMRX Nasdaq
  • BRID Nasdaq
  • Market Cap
  • IMRX 68.4M
  • BRID 70.3M
  • IPO Year
  • IMRX 2021
  • BRID N/A
  • Fundamental
  • Price
  • IMRX $2.60
  • BRID $7.65
  • Analyst Decision
  • IMRX Strong Buy
  • BRID
  • Analyst Count
  • IMRX 4
  • BRID 0
  • Target Price
  • IMRX $13.25
  • BRID N/A
  • AVG Volume (30 Days)
  • IMRX 2.4M
  • BRID 1.9K
  • Earning Date
  • IMRX 08-05-2025
  • BRID 06-02-2025
  • Dividend Yield
  • IMRX N/A
  • BRID N/A
  • EPS Growth
  • IMRX N/A
  • BRID N/A
  • EPS
  • IMRX N/A
  • BRID N/A
  • Revenue
  • IMRX N/A
  • BRID $224,673,000.00
  • Revenue This Year
  • IMRX N/A
  • BRID N/A
  • Revenue Next Year
  • IMRX N/A
  • BRID N/A
  • P/E Ratio
  • IMRX N/A
  • BRID N/A
  • Revenue Growth
  • IMRX N/A
  • BRID N/A
  • 52 Week Low
  • IMRX $1.00
  • BRID $7.52
  • 52 Week High
  • IMRX $3.83
  • BRID $14.69
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 70.10
  • BRID 40.57
  • Support Level
  • IMRX $1.66
  • BRID $7.64
  • Resistance Level
  • IMRX $2.24
  • BRID $7.88
  • Average True Range (ATR)
  • IMRX 0.32
  • BRID 0.17
  • MACD
  • IMRX 0.07
  • BRID -0.01
  • Stochastic Oscillator
  • IMRX 89.51
  • BRID 6.38

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

Share on Social Networks: